Inquiry into CDC Lab Kindles Debate On Best Approach to AIDS Research

ATLANTA—What is the role of basic research in an organization with an applied mission? That issue has surfaced in the recent investigation of the AIDS program at the Centers for Disease Control. A three-member panel from the Institute of Medicine, in a December report, concluded that one of the AIDS laboratory units had suffered from poor scientific management, low morale and productivity, and a lack of clear research goals. The AIDS lab was created in 1983, when knowledge about the diseas

Written byWilliam Check
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A three-member panel from the Institute of Medicine, in a December report, concluded that one of the AIDS laboratory units had suffered from poor scientific management, low morale and productivity, and a lack of clear research goals. The AIDS lab was created in 1983, when knowledge about the disease was scant, and virologists were given great leeway in their research.

Problems arose, said CDC Director James Mason, as researchers both inside and outside the Centers began to learn more about the disease. That new information led to a narrowing of the scope of the work at CDC.

"Our forte is epidemiological work, and the laboratory becomes a support service," Mason said. "That's not the role these people were interested in." Half of the dozen scientists who have worked in the lab have left or been transferred.

The Institute of Medicine investigation was formed in response to a request from Sen. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies